Condition: Skull Base Chordoma · Sponsor: CNAO National Center of Oncological Hadrontherapy
The study consists in the retrospective and prospective collection of imaging data (along with clinical information related to treatment) of skull-base chordoma patients treated with particle therapy, to derive imaging biomarkers which, integrated with advanced mathematical models, will allow predicting treatment outcome on a multi-scale basis.
This description comes directly from the study's public registry record.
Alberto Iannalfi, MD · 0382078501 · alberto.iannalfi@cnao.it
Cristina Bono, MSc · 0382078613 · cristina.bono@cnao.it
Always discuss trial participation with your own doctor first.
| CNAO | Pavia, Pv, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05888064